(Q46095596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

review article

1 reference

title

Acute-on-chronic liver failure in cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Richard Moreau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

10

Bernd Schnabl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

4

Rajiv Jalan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Patrick S Kamath

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Pere Ginès

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Frederik Nevens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Javier Fernández

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Uyen To

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Guadalupe García-Tsao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

9 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Disease Primers

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

16041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Resolution of liver fibrosis: basic mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Alterations of the human gut microbiome in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Comparison of current diagnostic criteria for acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Defining acute-on-chronic liver failure: East, West or Middle ground?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Toward an improved definition of acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: terminology, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: concept, natural history, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Disease tolerance as a defense strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Origin and physiological roles of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Control of adaptive immunity by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Innate immune sensing and signaling of cytosolic nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

How dying cells alert the immune system to danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Inflammation 2010: new adventures of an old flame

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Regulation of adaptive immunity by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Stress, inflammation, and defense of homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Pathological bacterial translocation in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Severe sepsis in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Effects of lipopolysaccharide on TNF-α production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Endoplasmic reticulum stress in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Sterile inflammation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Lipopolysaccharide-induced mitochondrial DNA depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Mitochondrial DNA stress primes the antiviral innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Role of Gut Microbiota in Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Altered profile of human gut microbiome is associated with cirrhosis and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Linkage of gut microbiome with cognition in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Characterization of fecal microbial communities in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The model for end-stage liver disease (MELD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Human serum albumin, systemic inflammation, and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Prednisolone or pentoxifylline for alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Antibiotic prophylaxis in cirrhosis: Good and bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Urinary biomarkers and progression of AKI in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Adrenocortical dysfunction in liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Coagulopathy in liver diseases: complication or therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Liver support strategies: cutting-edge technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Liver transplantation for acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Criteria for liver transplantation in ACLF and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Hospital readmissions among patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Long term health-related quality of life in survivors of sepsis in South West Wales: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Noncanonical inflammasome activation by intracellular LPS independent of TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

21 January 2018

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Compensated cirrhosis: Natural history and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Expanding consensus in portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Caspase target drives pyroptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

21 January 2018

Hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Single-centre validation of the EASL-CLIF Consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Bacterial infections in cirrhosis: A growing problem with significant implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

Inflammatory caspases are innate immune receptors for intracellular LPS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.41

31 March 2020

Identifiers

DOI

10.1038/NRDP.2016.41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27277335%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference